Skip to main content
Elsevier

Retina Assessments, Disease, and Treatments

  • 1st Edition, Volume 218 - June 26, 2026
  • Latest edition
  • Editor: Machelle T. Pardue
  • Language: English

Retina Assessments, Disease, and Treatments, Volume Two explores retinal disease, assessment, and treatment for rehabilitation of visual function. Focusing on major retinal diseas… Read more

Description

Retina Assessments, Disease, and Treatments, Volume Two explores retinal disease, assessment, and treatment for rehabilitation of visual function. Focusing on major retinal diseases and clinical assessments, including neuroimaging and electrophysiology, this volume highlights new restorative therapies such as gene therapy, stem cell therapy, retinal prosthetics, and novel tools to assess retinal function.

Key features

  • Provides a deep dive into the clinical aspects related to retinal therapy
  • Identifies the various diseases and corresponding treatments of the retina
  • Presents novel tools used for restoration and assessment of retinal function

Readership

Researchers in vision, retina, general neurologyGrad students in vision, retina, general neurology. Neurologists and Opthamologists treating retina disorders

Table of contents

Section A: Clinical Aspects

1. Fundus photography and AI analysis

2. Optical coherence tomography (OCT) and OCT-Angiography

3. Adaptive optics-scanning laser ophthalmoscope

4. Electroretinogram

5. Fundus autofluorescence

Section B: Diseases and treatments

6. Retinitis pigmentosa

7. Age-related macular degeneration

8. Diabetic retinopathy

9. Glaucoma

10. Retinal detachment

11. Retinal vascular disease (retinal artery occlusion)-TBD

12. Rare retinal disorders

Section F. Therapy

13. Gene therapy

14. Stem cells 1

15. Retinal prosthetics

Section G: Novel tools for retinal function

16. Retinal organoids

17. Optoretinogram

Product details

  • Edition: 1
  • Latest edition
  • Volume: 218
  • Published: June 26, 2026
  • Language: English

About the editor

MP

Machelle T. Pardue

Dr. Pardue received her B.S. in Zoology from the University of Wyoming and her doctorate in Vision Science and Biology at the University of Waterloo. Her post-doctorate training was completed at Loyola School of Medicine and Hines VA Hospital in Chicago. Dr. Pardue moved to Atlanta in 2000 to a joint position at the Atlanta VA Medical Center and Emory University Department of Ophthalmology. She moved her academic appointment to Biomedical Engineering at Georgia Tech in 2015. She became an ARVO Silver Fellow in 2016 and a Fellow of the American Institute of Medical and Biological Engineering in 2017. Dr. Pardue’s research interests are focused on developing treatments for people with vision loss. Her experience as a VA Research Scientist has given her an appreciation for the importance of translational research and the need to rapidly move treatments from the benchtop to the bedside. She is currently pursuing both pre-clinical and clinical studies to move treatments for retinal disease into the clinic. Her research has been continuously funded through the Department of Veterans Affairs (VA), NIH, and private companies. Dr. Pardue is a Research Career Scientist at the Atlanta VA Medical Center, and a Professor in Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. Dr. Pardue has served in several leadership roles at the Atlanta VA. She currently serves as the Chair of the Atlanta VA Research and Development Committee and is Associate Director of the Atlanta VA Center for Visual and Neurocognitive Rehabilitation. Her h index=36, with 101 documents, and 3868 citations. Among her most contributed research topics 2017-2021 were: Myopia, Defocus, Diabetic Retinopathy, Retina, Low Vision, and Vision Disorders.
Affiliations and expertise
Professor and Associate Chair of Faculty Development, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, USA